Bisphosphonate-related osteonecrosis of jaw의 치료에 대한 고찰

Bisphosphonates are widely used to treat osteoporosis, hypercalcemia of malignant tumor. Despite their clinical benefit, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a newly documented complication to patients receiving these drugs and first recognized by Marx in 2003. Thus,considerati...

Full description

Saved in:
Bibliographic Details
Published inJournal of the Korean Association of Oral and Maxillofacial Surgeons Vol. 36; no. 3; pp. 206 - 210
Main Authors 유경하(Kyung-Ha You), 윤규호(Kyu-Ho Yoon), 배정호(Jung-Ho Bae), 박재안(Jae-An Park), 박군찬(Gun-Chan Park), 신재명(Jae-Myung Shin), 백지선(Jee-Seon Baik), 정정권(Jeong-Kwon Cheong)
Format Journal Article
LanguageKorean
Published 대한구강악안면외과학회 30.06.2010
Korean Association Of Oral And Maxillofacial Surgeons
Subjects
치의학
Osteoporosis
Bisphosphonate
Osteonecrosis
Online AccessGet full text
ISSN2234-7550
2234-5930

Cover

More Information
Summary:Bisphosphonates are widely used to treat osteoporosis, hypercalcemia of malignant tumor. Despite their clinical benefit, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a newly documented complication to patients receiving these drugs and first recognized by Marx in 2003. Thus,consideration of prevention and needs regarding unequivocal treatment regimen have emerged. Recently, several authors emphasized reports on appropriate clinical availability of surgical approach. It serves to concern about guideline for surgical and conservative treatment modalities. So, it is the purpose of this paper to review the current literatures about treatment regimens of BRONJ. KCI Citation Count: 1
Bibliography:G704-000546.2010.36.3.012
ISSN:2234-7550
2234-5930